Lev Bubis Profile
Lev Bubis

@LevBubis

Followers
125
Following
57
Media
1
Statuses
21

Toronto, Ontario
Joined January 2017
Don't wanna be here? Send us removal request.
@LevBubis
Lev Bubis
3 years
RT @DeMadaria: A short history (14 slides) of adjuvant therapy for pancreatic cancer #TheAmylaseSchool #HiloAEG #UEGambassador #GItwitter @….
0
47
0
@LevBubis
Lev Bubis
3 years
RT @MPishvaian: #GI22. 📢Before the meeting gets rolling, I would like to present the abstracts I am keeping my eye👁️on. My Top 10(ish) #Pan….
0
24
0
@LevBubis
Lev Bubis
4 years
RT @SerranoAybar: PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancreatic stump to preve… http….
0
6
0
@LevBubis
Lev Bubis
6 years
RT @ICESOntario: New @ICESOntario study led by @LevBubis & @alyson_mahar looked at patient-reported symptom severity among 22,650 cancer ou….
0
2
0
@LevBubis
Lev Bubis
6 years
RT @DrNCoburn: Congratulations @niv_vela on his GOLDEN STETHOSCOPE AWARD!! An Outstanding @uoftmedicine #medstudent in the Peters-Boyd Acad….
0
1
0
@LevBubis
Lev Bubis
6 years
RT @VGupta_MD: Our study in @AATSJournals looking at esophagectomy readmissions in Ontario:. 1. No change in readmission rate over 13 yrs.2….
0
9
0
@LevBubis
Lev Bubis
6 years
RT @halletjulie: Important info on pt-reported symptom burden after #NET diagnosis now in @OncJournal. Frequent symptoms and burden persist….
0
5
0
@LevBubis
Lev Bubis
6 years
RT @seacm: Incorporating Patient Preferences in Non-inferiority Trials: Our proposal to improve the clinical utility and interpretation of….
0
5
0
@LevBubis
Lev Bubis
7 years
RT @DrNCoburn: An assessment of 23,840 Stage I-III breast cancer patients shows high rates of symptom burden, especially in younger women,….
0
5
0
@LevBubis
Lev Bubis
7 years
RT @JBBC: Cancer-related fatigue (CRF) is increasingly recognised as one of the most common and distressing side effects of cancer and its….
0
20
0
@LevBubis
Lev Bubis
7 years
RT @EricTopol: Individualized post-op management w/ e-health using patient reported outcomes, a RCT @TheLancet http….
0
16
0
@LevBubis
Lev Bubis
7 years
RT @DrNCoburn: Can we improve surgical outcomes by promoting exercise, nutrition, and lifestyle modifications prior to major operations? @S….
0
13
0
@LevBubis
Lev Bubis
7 years
RT @ASCO: Phase III trial: People with surgically removed pancreatic cancer who received mFOLFIRINOX chemo lived a median of 20 months long….
0
90
0
@LevBubis
Lev Bubis
7 years
RT @scottrberry: PRODIGE 7 : HIPEC added to cytoreductive surgery for isolated CRC peritoneal mets does not improve OS and increases late p….
0
9
0
@LevBubis
Lev Bubis
7 years
RT @NEJM: Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) #….
0
226
0
@LevBubis
Lev Bubis
7 years
RT @TheLancet: Immunoscore for the classification of #coloncancer: study provides a reliable estimate of the risk of recurrence in patients….
0
25
0
@LevBubis
Lev Bubis
7 years
RT @DrNCoburn: Congratulations to Yunni Jeong for her Best Presentation Award at the 2018 Korean Gastric Cancer Association meeting! @UofTS….
0
4
0
@LevBubis
Lev Bubis
7 years
Congratulations to @DrNCoburn! So very well-deserved!
0
0
1
@LevBubis
Lev Bubis
7 years
Laura Davis from @DrNCoburn's team presenting research on province-wide cancer patient-reported outcomes data at CCO Research Day 2018! @ICESOntario @Sunnybrook #PROs #CancerResearch
Tweet media one
0
0
5